| Literature DB >> 28831750 |
Ryutaro Kotaki1, Hiroshi Higuchi1, Daisuke Ogiya2, Yasuhiro Katahira1, Natsumi Kurosaki1, Naoko Yukihira1, Jun Ogata1, Haruna Yamamoto1, Syakira Mohamad Alba3, Azran Azhim4, Tatsuo Kitajima3, Shigeaki Inoue5, Kazuhiro Morishita6, Koh Ono7, Ryo Koyama-Nasu8, Ai Kotani9,10.
Abstract
miR-1 and miR-133 are clustered on the same chromosomal loci and are transcribed together as a single transcript that is positively regulated by ecotropic virus integration site-1 (EVI1). Previously, we described how miR-133 has anti-tumorigenic potential through repression of EVI1 expression. It has also been reported that miR-1 is oncogenic in the case of acute myeloid leukemia (AML). Here, we show that expression of miR-1 and miR-133, which have distinct functions, is differentially regulated between AML cell lines. Interestingly, the expression of miR-1 and EVI1, which binds to the promoter of the miR-1/miR-133 cluster, is correlative. The expression levels of TDP-43, an RNA-binding protein that has been reported to increase the expression, but inhibits the activity, of miR-1, were not correlated with expression levels of miR-1 in AML cells. Taken together, our observations raise the possibility that the balance of polycistronic miRNAs is regulated post-transcriptionally in a hierarchical manner possibly involving EVI1, suggesting that the deregulation of this balance may play some role in AML cells with high EVI1 expression.Entities:
Keywords: AML; EVI1; miR-1; miR-133
Mesh:
Substances:
Year: 2017 PMID: 28831750 DOI: 10.1007/s12185-017-2314-1
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490